...
首页> 外文期刊>Infection and Drug Resistance >Molecular Investigations of Linezolid Resistance in Enterococci OptrA Variants from a Hospital in Shanghai
【24h】

Molecular Investigations of Linezolid Resistance in Enterococci OptrA Variants from a Hospital in Shanghai

机译:上海医院肠球菌OPTRA耐药性抗线性抗性的分子研究

获取原文

摘要

Purpose: The OptrA protein is a member of ATP-binding cassette (ABC) transporters, a transporter family which can confer resistance to oxazolidinone antibiotics by transferring plasmid. We aim to describe the distribution of optrA -harbored Enterococcus in Huashan hospital in 2017 and to address the effects of optrA mutations on the susceptibility of linezolid antibiotic drug. Methods: Linezolid-resistance-related genes were tested for Enterococcus by polymerase chain reaction (PCR) and then sequenced for amino acid substitution site analysis. Broth microdilution and agar dilution test were applied to determine the minimal inhibitory concentration (MIC) of linezolid for Enterococcus containing optrA . Pulsed field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) were used to evaluate the genotypes of optrA -positive isolates. To verify the functions of two main optrA variants, optrA over-expressing strains were constructed. Results: Among 20 optrA -positive strains, only two were resistant to linezolid. No amino acid substitution existed in 23S rRNA V domain among Enterococcus faecalis . None had cfr, cfr (B) or cfr (C) genes. F101L and G4D/K/R or T150A were the main substitutions of ribosomal protein L4, L3, respectively. We found one Enterococcus faecium isolate co-contained optrA and poxtA and another E. faecalis isolate co-contained optrA and cfr (D), but they were not resistant to linezolid. Among 20 optrA -positive strains, ST-16 was the main type. Two main optrA variants KD (T112K, Y176D) and RDK (I104R, Y176D, E256K) slightly raised enterococci’s MIC of linezolid. Conclusion: OptrA exists in linezolid non-resistant enterococci with diverse amino acid substitutions. The variants play different roles in changing the MIC of linezolid.
机译:目的:OPTRA蛋白是ATP结合盒(ABC)转运蛋白的成员,其通过转移质粒能够赋予恶唑烷酮抗生素的抗性。我们的目的是在2017年描述华山医院OPTRA-Harboced Entococcus的分布,并解决OPTRA突变对线唑胺抗生素药物易感性的影响。方法:通过聚合酶链式反应(PCR)对肠球菌进行肠球菌进行抗毒性相关基因,然后对氨基酸取代位点分析进行测序。施用肉汤微量稀释试验和琼脂稀释试验以确定含有OPTRA的肠球菌的Linezolid的最小抑制浓度(MIC)。脉冲场凝胶电泳(PFGE)和多层序列键入(MLST)用于评估OPTRA阳性分离株的基因型。为了验证两个主要OPTRA变体的功能,构建了OPTRA过表达菌株。结果:在20次OPTRA - 阳性菌株中,只有两种抗LINEZOLID。在肠球菌粪便中,在23s rRNA v结构域中不存在氨基酸取代。没有CFR,CFR(B)或CFR(C)基因。 F101L和G4D / K / R或T150A分别是核糖体蛋白L4,L3的主要取代。我们发现一个肠球菌分离型共同含有的OPTRA和POXTA,另一个E.粪便分离物共同含有OPTRA和CFR(D),但它们不抵抗线唑胺。在20次OPTRA - 阳性菌株中,ST-16是主要类型。两个主要的OPTRA变体KD(T112K,Y176D)和RDK(I104R,Y176D,E256K)略微提高了肠球菌的LINEzolid的MIC。结论:具有多样化氨基酸取代的Linezolid非抗性肠球菌中存在OPTRA。变种在改变Linezolid的MIC时发挥着不同的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号